Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Associate Director, Process Chemistry will lead small-molecule process development and manufacturing efforts supporting clinical-stage drug substance programs, with a primary focus on early-phase clinical manufacturing. This role spearheads the design, development and technical oversight of synthetic routes for programs ranging from IND-enabling studies through Phase 2, ensuring that Drug Substance supply is delivered with speed, quality, and phase-appropriate controls. The Associate Director will work closely with cross-functional teams across CMC, analytical development, quality, regulatory, and manufacturing to advance development programs and support clinical timelines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
101-250 employees